Category: COVID-19

Etching the Pain of Covid Into the Flesh of Survivors

Memorial tattoos have grown more popular in recent years. Since parlors reopened after the lockdown, inkers have found that many people are eager to memorialize relatives and friends lost to covid.

Etching the Pain of Covid Into the Flesh of Survivors

Memorial tattoos have grown more popular in recent years. Since parlors reopened after the lockdown, inkers have found that many people are eager to memorialize relatives and friends lost to covid.

Lifting DC’s Strict Indoor Mask Mandate Triggers Mix of Confusion, Anxiety and Relief

Some business owners, wondering whether it’s too soon to ease the requirement, long for more guidance and support from the mayor.

Why You Can’t Find Cheap At-Home Covid Tests

You probably won’t be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.

Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests

The promising antiviral drugs to treat covid can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many people won’t meet. Here’s why.

Vaccine-or-Test Requirements Increase Work and Costs for Governments

But state and local officials embrace the requirement because it creates a safer workplace while allowing employees to continue working.

What Happens After a Campus Suicide Is a Form of Prevention, Too

The scientific term is “postvention,” and it informs how to navigate the emotional challenges that follow such a tragedy.

KHN’s ‘What the Health?’: Boosting Confusion

Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.

Schools, Pediatricians Look to Make Up Lost Ground on Non-Covid Vaccinations

Health officials hope the rollout of covid shots for young children and other initiatives will boost routine vaccine rates that dropped during the pandemic and narrow socioeconomic disparities.

Quarantine and Tracing Rules Are All Over the Map for Students

The Centers for Disease Control and Prevention offers guidance but calls for localities to set quarantine rules for unvaccinated children exposed to someone with covid-19. That’s led to a pandemic patchwork of rules.